harvard medical school: "cgrp: a new era for migraine treatment." .
the news highlighted another factor in the chinese threat: regardless of the different regulatory framework, many researchers think the data they report is valid. http://lm360.us/Durepo-sister-of-Stensrud-from-Xocourt?Ballifgra=173